LONDON BROKER RATINGS: Citi ups Admiral; Peel Hunt cuts Sabre
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 13,104.00p on 29-07-2026 at 08:08:07 |
|---|---|
| Change | 164.00p 1.27% |
| Buy | 13,106.00p |
| Sell | 13,102.00p |
| Last Trade: | Sell 29.00 at 13,104.00p |
| Day's Volume: | 208,439 |
| Last Close: | 12,940.00p |
| Open: | 13,014.00p |
| ISIN: | GB0009895292 |
| Day's Range | 12,978.00p - 13,126.00p |
| 52wk Range: | 10,784.00p - 15,730.00p |
| Market Capitalisation: | £203.23b |
| VWAP: | 13,077.00901p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 29 | 13,104.00p | Automatic Execution |
09:07:55 - 29-Jul-26 |
| Sell* | 65 | 13,104.00p | Automatic Execution |
09:07:55 - 29-Jul-26 |
| Sell* | 63 | 13,106.00p | Automatic Execution |
09:07:47 - 29-Jul-26 |
| Unknown* | 0 | 13,110.00p | SI Trade |
09:07:46 - 29-Jul-26 |
| Sell* | 212 | 13,106.061p | Ordinary |
09:07:45 - 29-Jul-26 |
| Sell* | 18 | 13,106.00p | Automatic Execution |
09:07:28 - 29-Jul-26 |
| Buy* | 27 | 13,106.00p | Automatic Execution |
09:07:27 - 29-Jul-26 |
| Buy* | 25 | 13,106.00p | Automatic Execution |
09:07:27 - 29-Jul-26 |
| Buy* | 24 | 13,104.00p | Automatic Execution |
09:07:27 - 29-Jul-26 |
| Buy* | 27 | 13,102.00p | Automatic Execution |
09:07:27 - 29-Jul-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Jul 2026 7:10 am | RNS | Update on Ultomiris Phase III trial in HSCT-TMA |
| 27th Jul 2026 7:05 am | RNS | Sone-Ve improved survival in gastric cancers |
| 27th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 23rd Jul 2026 7:00 am | RNS | Etcamah approved in the EU for ER+ breast cancer |
| 14th Jul 2026 7:00 am | RNS | AstraZeneca licenses novel EGFR inhibitor |
| 9th Jul 2026 7:00 am | RNS | Update on CARDIO-TTRansform Phase III trial |
| 1st Jul 2026 3:05 pm | RNS | Admission of Further Securities to Trading |
| 1st Jul 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Jun 2026 7:30 am | RNS | Enhertu approved in EU for HER2+ solid tumours |
| 29th Jun 2026 7:00 am | RNS | Datroway recommended for approval in EU for TNBC |